Adolescents and young adults with cancer have substantially different clinical and psychological needs compared to those of pediatric patients and of older adult patients. We describe the development of an Italian national project dedicated to adolescents and young adults with cancer.
BarrRDFerrariARiesL, et al. Cancer in adolescents and young adults: a narrative review of the current status and a view of the future. JAMA Pediatr2016; 170: 495–501.
2.
FerrariAThomasDFranklinAR, et al. Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol2010; 28: 4850–4857.
3.
FerrariABarrRD. International evolution in AYA oncology: current status and future expectations. Pediatr Blood Cancer2017; 64: e26528.
4.
What should the age range be for AYA oncology?J Adolesc Young Adult Oncol2011; 1: 3–10.
5.
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, LiveStrong Young Adult Alliance. Closing the gap: research and care imperatives for adolescents and young adults with cancer: a report of the Adolescent and Young Adult Oncology Progress Review Group. Available at: https://www.livestrong.org/sites/default/files/what-we-do/reports/ayao_prg_report_2006_final.pdf
6.
TramaABottaLSteliarova-FoucherE. Cancer burden in adolescents and young adults: a review of epidemiological evidence. Cancer J2018; 24: 256–266.
7.
BleyerAFerrariAWhelanJBarrRD. Global assessment of cancer incidence and survival in adolescents and young adults. Pediatr Blood Cancer2017; 64.
8.
BarrRDRiesLAGTramaA, et al. A system for classifying cancers diagnosed in adolescents and young adults. Cancer2020; 126: 4634–4659.
9.
OsbornMJohnsonRThompsonK, et al. Models of care for adolescent and young adult cancer programs. Pediatr Blood Cancer2019; 66: e27991.
10.
SironiGBarrRDFerrariA. Models of care: there is more than one way to deliver. Cancer J2018; 24: 315–320.
11.
SenderLZabokrtskyKB. Adolescent and young adult patients with cancer: a milieu of unique features. Nat Rev Clin Oncol2015; 12: 465–480.
12.
FerrariAStarkDPeccatoriFA, et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE). ESMO Open2021; Apr;6(2): 100096.
13.
SaloustrosEStarkDPMichailidouK, et al. The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey. ESMO Open2017; 2: e000252.
14.
TramaABottaLFoschiR, et al. Survival of European adolescents and young adults diagnosed with cancer in 2000-2007: latest EUROCARE-5 results. Lancet Oncol2016; 17: 896–906.
15.
TramaABernasconiAMcCabeMG, et al. Is the cancer survival improvement in European and American adolescent and young adults still lagging behind that in children?Pediatr Blood Cancer2019; 66: e27407.
16.
HoughRSandhuSKhanM, et al. Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England. BMJ Open2017; 7: e017052.
17.
WolfsonJARichmanJSSunCL, et al. Causes of inferior outcome in adolescents and young adults with acute lymphoblastic leukemia: across oncology services and regardless of clinical trial enrollment. Cancer Epidemiol Biomarkers Prev2018; 27: 1133–1141.
18.
BleyerAMontelloMBuddT, et al. National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer2005; 103: 1891–1897.
19.
BleyerWATejedaHMurphySB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health1997; 21: 366–373.
20.
FerrariAMontelloMBuddT, et al. The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer2008; 50: 1101–1104.
21.
FerrariABleyerA. Participation of adolescents with cancer in clinical trials. Cancer Treat Rev2007; 33: 603–608.
22.
FernLDaviesSEdenT, et al. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer2008; 99: 1967–1974.
23.
FerrariATramaADe PaoliA, et al. Access to clinical trials for adolescents with soft tissue sarcomas: enrollment in European Pediatric Soft Tissue Sarcoma Study Group (EpSSG) protocols. Pediatr Blood Cancer2017; 64.
24.
SmithMASeibelNLAltekruseSF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol2010; 28: 2625–2634.
25.
VeneroniLMarianiLVulloSL, et al. Symptom interval in pediatric patients with solid tumors: adolescents are at greater risk of late diagnosis. Pediatr Blood Cancer2013; 60: 605–610.
26.
FernLALewandowskiJACoxonKM, et al. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol2014; 15: e341–e350.
27.
TaiEBuchananNWesterveltL, et al. Treatment setting, clinical trial enrollment, and subsequent outcomes among adolescents with cancer: a literature review. Pediatrics2014; 133 (Suppl 3): S91–S97.
28.
de RojasTNevenATeradaM, et al. Access to clinical trials for adolescents and young adults with cancer: a meta-research analysis. JNCI Cancer Spectr2019; 3: pkz057.
29.
GasparNMarshallLVBinnerD, et al. Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE. Ann Oncol2018; 29: 766–771.
30.
ChukMKMulugetaYRoth-ClineM, et al. Enrolling adolescents in disease/target-appropriate adult oncology clinical trials of investigational agents. Clin Cancer Res2017; 23: 9–12.
31.
PearsonADHeroldRRousseauR, et al. Implementation of mechanism of action biology-driven early drug development for children with cancer. Eur J Cancer2016; 62: 124–131.
32.
PearsonADHeenenDKearnsPR, et al. 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers. Lancet Oncol2018; 19: 285–287.
33.
GoreLIvySPBalisFM, et al. Modernizing clinical trial eligibility: recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Minimum Age Working Group. J Clin Oncol2017; 35: 3781–3787.
34.
TaylorRMSolankiAAslamN, et al. A participatory study of teenagers and young adults views on access and participation in cancer research. Eur J Oncol Nurs2016; 20: 156–164.
35.
TaylorRMAslamNLeaS, et al. Optimizing a retention strategy with young people for BRIGHTLIGHT, a longitudinal cohort study examining the value of specialist cancer care for young people. J Adolesc Young Adult Oncol2017; 6: 459–469.
36.
AbramsANHazenEPPensonRT. Psychosocial issues in adolescents with cancer. Cancer Treat Rev2007; 33: 622–630.
37.
ClericiCAMassiminoMCasanovaM, et al. Psychological referral and consultation for adolescents and young adults with cancer treated at a pediatric oncology unit. Pediatr Blood Cancer2008; 51: 105–109.
38.
MascarinMMilanoGMBertolottiM, et al. Discussing communication issues and needs with adolescents suffering from cancer. Tumori2021; 107: 360–363.
39.
MorganSDaviesSPalmerS, et al. Sex, drugs, and rock 'n' roll: caring for adolescents and young adults with cancer. J Clin Oncol2010; 28: 4825–4830.
40.
SilvaMBarrettaFLukschR, et al. Adolescents with cancer on privacy: a fact-finding survey on the need for confidentiality and space. Tumori2021; 107: 452–457.
41.
JakesADMarec-BerardPPhillipsRS, et al. Critical review of clinical practice guidelines for fertility preservation in teenagers and young adults with cancer. J Adolesc Young Adult Oncol2014; 3: 144–152.
42.
VeneroniLBagliaccaEPSironiG, et al. Investigating sexuality in adolescents with cancer: patients talk of their experiences. Pediatr Hematol Oncol2020; 37: 223–234.
43.
TaylorRMFernLABarberJ, et al. Longitudinal cohort study of the impact of specialist cancer services for teenagers and young adults on quality of life: outcomes from the BRIGHTLIGHT study. BMJ Open2020; 10: e038471.
44.
Hayes-LattinBMathews-BradshawBSiegelS. Adolescent and young adult oncology training for health professionals: a position statement. J Clin Oncol2010; 28: 4858–4861.
45.
StarkDBielackSBrugieresL, et al. Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project. Eur J Cancer Care2016; 25: 419–427.
46.
Bozovic-SpasojevicIBalsatMBlondeelA, et al. A European network for teenagers and young adults with cancer. J Adolesc Young Adult Oncol2021; 10: 117–119.
47.
FerrariADamaEPessionA, et al. Adolescents with cancer in Italy: entry into the National Cooperative Pediatric Oncology Group AIEOP trials. Eur J Cancer2009; 45: 328–334.
48.
FerrariAAricòMDiniG, et al. Upper age limits for accessing pediatric oncology centers in Italy: a barrier preventing adolescents with cancer from entering national cooperative AIEOP trials. Pediatr Hematol Oncol2012; 29: 55–61.
49.
FerrariARondelliRPessionA, et al. Adolescents with cancer in Italy: improving access to national cooperative pediatric oncology group (AIEOP) centers. Pediatr Blood Cancer2016; 63: 1116–1119.
50.
FerrariA. The challenge of access to care for adolescents with cancer in Italy: national and local pediatric oncology programs: international perspectives on AYAO, part 2. J Adolesc Young Adult Oncol2013; 2: 112–117.
51.
FerrariABernasconiASironiG, et al. Where are adolescents with soft tissue sarcomas treated? An Italian national study on referral based on the hospital discharge records. J Adolesc Young Adult Oncol2020; 9: 190–195.
52.
ZeccaMFerrariAQuarelloP, et al. Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP). Tumori2021; 107: 370–375.
53.
MagniCMaggioniFRicciA, et al. “There’s no reason why”: a campaign to raise cancer awareness among adolescents. Tumori2016; 2016: 270–275.
54.
MagniCSegrèCFinziC, et al. Adolescents’ health awareness and understanding of cancer and tumor prevention. When and why an adolescent decides to consult a physician. Pediatr Blood Cancer2016; 63: 1357–1361.
55.
SilvaMChisariMSignoroniS, et al. Winners’ Cup: a national football tournament brings together adolescent patients with cancer from all over Italy. Tumori2017; 103: e25–e29.
56.
MascarinMTruccoloIBytherE, et al. Cancer, adolescence, and their peers: “They’ll give you a story.”J Cancer Educ2014; 29: 434–440.
57.
FerrariAClericiCACasanovaM, et al. The Youth Project at the Istituto Nazionale Tumori in Milan. Tumori2012; 98: 399–407.
58.
FerrariAVeneroniLClericiCA, et al. Clouds of Oxygen: adolescents with cancer tell their story in music. J Clin Oncol2015; 33: 218–221.
59.
FerrariAGaggiottiPSilvaM, et al. Searching for happiness. J Clin Oncol2017; 35: 2209–2212.
60.
FerrariASilvaMVeneroniL, et al. Measuring the efficacy of a project for adolescents and young adults with cancer: a study from the Milan Youth Project. Pediatr Blood Cancer2016; 63: 2197–2204.
61.
Pagani BagliaccaESilvaMVeneroniL, et al. YOUTH: the sweatshirt collection created by adolescent cancer patients on the Youth Project in Milan. Lancet Oncol2020; 21: 341–342.
62.
FerrariAQuarelloPMascarinM, et al. Evolving services for adolescents with cancer in Italy: access to pediatric oncology centers and dedicated projects. J Adolesc Young Adult Oncol2020; 9: 196–201.
63.
FerrariA. Adolescents with cancer in Italy: from local projects to a national coordinated program. Tumori2013; 99: 186e–187e.
64.
FerrariA. Italian pediatric oncologists and adult medical oncologists join forces for adolescents with cancer. Pediatr Hematol Oncol2014; 31: 574–575.
65.
TralongoACAntonuzzoAPronzatoP, et al. Management of chemotherapy-induced neutropenia in patients with cancer: 2019 guidelines of the Italian Medical Oncology Association (AIOM). Tumori2020; 106: 273–280.
66.
SbranaAAntonuzzoABrunelloA, et al. Management of anemia in patients with cancer: 2019 Italian Association of Medical Oncology (AIOM) guidelines. Tumori2020; 106: 337–345.
